In an attempt to decrease the incidence of central venous catheter sep
sis in children with cancer, we conducted a study to evaluate the bene
fit of adding broad-spectrum antibiotics to the catheter ''flush solut
ion.'' In a prospective, placebo-controlled, double-blinded, randomize
d trial, 69 children with different types of malignancies were studied
. The central venous catheters in these children were flushed with eit
her the standard solution (normal saline + 100 U/ml of heparin) or the
study solution (25 mu g/ml of both amikacin and vancomycin added to t
he standard solution). At the conclusion of the study, 64 children wit
h a total of 67 indwelling central venous lines were assessable. The t
otal catheter days on study were 20,700 days, with a median of 323 cat
heter days per patient. We documented 10 events of catheter-related in
fections (0.49 events/1,000 catheter days at risk). Five of these even
ts were catheter-related sepsis (0.24 sepses/1,000 catheter days): two
were fungal and three were bacterial. Due to the low incidence of cat
heter-related sepsis in this study, no statement regarding the prophyl
actic use of antibiotics could be made. The extremely low rate of cath
eter-related sepsis reported herein may be retrospectively attributed
to continuous staff education regarding aseptic techniques in handling
these catheters. Staff education is essential, and probably the most
effective factor in preventing catheter-related sepsis. (C) 1996 Wiley
-Liss, Inc.